SRRT and glioblastoma: We found that the tumor volumes in NOD/SCID mice bearing U87 glioblastoma cells infected with control shRNA displayed large tumors extending throughout the whole right hemisphere, whereas mice bearing Ars2 shRNA cells displayed barely visible tumors (Fig. 7B,C).